Daniel S. Reuland
- M.D., M.P.H.
- Cancer Prevention and Control
- School of Medicine
- UNC-Chapel Hill
- 5039 Old Clinic Building
Area of Interest
Dr. Reuland is a general internist, health services researcher, and Associate Professor at the University of North Carolina School of Medicine in the Division of General Internal Medicine and Clinical Epidemiology. His main research interests currently fall into two related areas. The first is enhancing our understanding of how to improve cancer control communication in primary care for diverse patient populations. Specifically, he has focused on addressing barriers to colorectal cancer (CRC) screening faced by Hispanic/ Latino populations, as well as barriers faced by other vulnerable groups including Medicaid populations, other racial/ethnic minorities, and populations with low health literacy. In 2009, he received a career development award from the American Cancer Society (ACS) to develop and test decision support interventions aimed at enhancing communication and informed decision-making in primary care for Spanish speaking populations. Using this award along with additional project support from NC Translational & Clinical Sciences (NCTraCS) Institute and a Lineberger Center Population Sciences Center Research Award, he completed the development and testing of a Spanish language multimedia colorectal cancer screening decision aid that can be used in clinical practice. He was recently awarded a Research Scholar Grant from the American Cancer Society (RSG-13-165-01-CPPB) to test a combined intervention involving a CRC screening decision aid plus clinic-based bilingual patient navigator in a multi-site clinical trial at primary care clinics serving diverse, vulnerable patient populations in North Carolina and New Mexico.
A second (new) area of inquiry is promoting informed and shared decision making about lung cancer screening using low dose computed tomography (LDCT). Recent evidence for the National Lung Screening Trial (NLST) suggests that screening high-risk patients with LDCT can reduce lung cancer mortality. Unfortunately, however, screening also identifies many benign nodules (i.e. it has a high false positive rate), which leads to additional imaging tests and, in some cases, invasive procedures. As with many cancer screening tests, achieving informed and shared decision making about LDCT screening for lung cancer in clinical practice is challenging, particularly when it requires helping patients who have limited health literacy understand and make tradeoffs among a variety of potential benefits and harms of screening. A related facet of this research is the promotion of smoking cessation among screening eligible patients who smoke.
Awards and Honors
1986 University of Michigan, Honors Program, Phi Beta Kappa, Otto Graf Award Finalist
1991 Johns Hopkins University, Finalist, Medical Student Research Award
2004- Co-director, Comprehensive Advanced Medical Program of Spanish (CAMPOS), School of Medicine, UNC Chapel Hill
2006-2008 University of North Carolina, K30 Scholar
2007- Co-director, UNC Center for Latino Health
2008- Member, UNC Program on Health Literacy (Darren DeWalt MD MPH, Director)
2009 Nominee, Graduate School Impact Award, University of North Carolina,
2009-2012 Recipient of American Cancer Society’s Cancer Control Career Development Award (CCCDA) for Primary Care Physicians
2010- Appointed Research Fellow, Cecil G. Sheps Center for Health Services Research, UNC- Chapel Hill
2010-2011 Co-chair, Health Disparities Scientific Abstract Review Committee; Society of General Internal Medicine (SGIM) 2011 Annual National Meeting
2010- Associate member, Lineberger Comprehensive Cancer Center
2011- Director, Expanding Networks for Latinos through Community Engagement (ENLaCE) Initiative, Community Engagement Core, NC Translational & Clinical Sciences Institute
2012- Member, UNC Research Center for Excellence in Clinical Preventive Services (UNC-ReCPS)